NU 451 Women and Men\u2018s Health, Infectious Disease, and Hematologic Disorders<\/strong><\/p>\n \u00a0<\/span><\/p>\n The case study NU 451 Women and Men\u2018s Health, Infectious Disease, and Hematologic Disorders portrays HH who has been admitted for three days due to CAP. He has a history of COPD, HTN, hyperlipidemia<\/a>, and diabetes. HH\u2019s health needs include limited oxygen perfusion as evidenced by a SPO2 of 92% caused by CAP. The patient\u2019s COPD may have contributed to CAP which occurs when bacteria breeds in the mucus clogged in the airways. He also has fever of 100.9 caused by respiratory infection. Besides, he has leukocytosis as seen with an elevated WBC and neutrophil account, indicating an underlying systemic infection. Furthermore, he has nutritional needs since he is not tolerating diet due to nausea and vomiting. The patient has hyperglycemia with elevated glucose levels of 143 mg\/dL.<\/span><\/p>\n The recommended treatment will include antibiotics, antiemetics, antidiabetic, and lipid-lowering medications. The patient will be continued on IV Ceftriaxone 1 gm for a total of five days. IV Azithromycin will be switched to oral Azithromycin 500 mg OD for 5 days because the patient demonstrates improvement (Metlay et al., 2019). Antiemetics will include Metoclopramide 10 mg PO administered 30 minutes before meals to alleviate nausea and vomiting and in turn promote dietary intake. Metformin 850 mg\/day PO will be recommended for diabetes and to maintain glycemic levels at optimum. It is recommended for overweight\/obese diabetic patients because it does not cause weight gain unlike other hypoglycemic agents (Flory & Lipska, 2019). The recommended lipid-lowering agent will be Lipitor 20 mg\/day PO to manage hyperlipidemia and lower the patient\u2019s risk of cardiovascular conditions.\u00a0<\/span>\u00a0<\/span><\/p>\n My recommended patient education strategy for HH will be to employ the<\/span>\u00a0<\/span><\/p>\n “Teach-back” method. When using this method, the provider explains the conditions, treatment options, and self-care strategies to the patient (Yen & Leasure, 2019). The provider then asks the patient to repeat what they have understood in their own words.<\/span>\u00a0<\/span><\/p>\n Flory, J., & Lipska, K. (2019). Metformin in 2019.\u202f<\/span>JAMA<\/span><\/i>,\u202f<\/span>321<\/span><\/i>(19), 1926\u20131927. https:\/\/doi.org\/10.1001\/jama.2019.3805<\/a><\/span>\u00a0<\/span><\/p>\n Metlay, J. P., Waterer, G. W., & Long, A. C. (2019). AMERICAN THORACIC SOCIETY Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.\u202f<\/span>Am J Crit Care Med<\/span><\/i>,\u202f<\/span>200<\/span><\/i>(7), 45-67. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST<\/a><\/span>\u00a0<\/span><\/p>\n Yen, P. H., & Leasure, A. R. (2019). Use and Effectiveness of the Teach-Back Method in Patient Education and Health Outcomes.\u202f<\/span>Federal practitioner : for the health care professionals of the VA, DoD, and PHS<\/span><\/i>,\u202f<\/span>36<\/span><\/i>(6), 284\u2013289.<\/span>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n The case scenario portrays a 46-year-old who reports hot flushes, night sweats, and genitourinary symptoms. She is obese, has history<\/span><\/p>\n of HTN and ASCUS, and has a family history of breast cancer. The patient\u2019s health needs include vasomotor symptoms like the hot flushes, night sweats, and genitourinary symptoms, which are probably because she is in the perimenopause phase. She has weight concerns since she is obese, which puts her at risk of diabetes and cardiovascular conditions. In addition, she has high BP of 150\/90 despite being on antihypertensive treatment with Norvasc and HCTZ. The patient\u2019s chronic hypertension increases her risk of developing stroke, heart failure and kidney failure. Furthermore, the client is at risk of cervical cancer because of her ASCUS history as well as breast cancer owing to her family history of breast cancer.<\/span>\u00a0<\/span><\/p>\n \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The recommended treatment plan is Hormone replacement therapy (HRT) with combined estrogen and progesterone to alleviate the vasomotor symptoms. Palacios et al. (2019) explain that Estrogen is the primary active component of HRT and is the \u2018gold standard\u2019 for managing vasomotor symptoms. However, chronic exposure of the endometrium to unopposed estrogen is associated with a risk of endometrial hyperplasia and cancer (Bansal & Aggarwal, 2019). Thus, progesterone is included in HRT in women with an intact uterus. The HRT for this patient will include Estradiol transdermal patch 0.025 mg and Micronized progestin 100 mg OD. Transdermal patches are preferred due to their lower risk of thromboembolism, stroke, vaginal bleeding, and breast tenderness.<\/span>\u00a0<\/span><\/p>\n I would recommend the \u201cTeach-back\u201d method in educating the patient on self-care interventions. The strategy enables the provider to assess if the information they have taught the patient has been properly received and grasped (Talevski et al., 2020).This is because the provider teaches a concept and then instructs the patient to explain what they have learned based on their understanding.\u00a0<\/span>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Bansal, R., & Aggarwal, N. (2019). Menopausal Hot Flashes: A Concise Review.\u202f<\/span>Journal of mid-life health<\/span><\/i>,\u202f<\/span>10<\/span><\/i>(1), 6\u201313. <\/span>https:\/\/doi.org\/10.4103\/jmh.JMH_7_19<\/span><\/a>\u00a0<\/span><\/p>\n Palacios, S., Stevenson, J. C., Schaudig, K., Lukasiewicz, M., & Graziottin, A. (2019). Hormone therapy for first-line management of menopausal symptoms: Practical recommendations.\u202f<\/span>Women’s health (London, England)<\/span><\/i>,\u202f<\/span>15<\/span><\/i>, 1745506519864009. https:\/\/doi.org\/10.1177\/1745506519864009<\/a><\/span>\u00a0<\/span><\/p>\n Talevski, J., Wong Shee, A., Rasmussen, B., Kemp, G., & Beauchamp, A. (2020). Teach-back: A systematic review of implementation and impacts.\u202f<\/span>PloS one<\/span><\/i>,\u202f<\/span>15<\/span><\/i>(4), e0231350. https:\/\/doi.org\/10.1371\/journal.pone.0231350<\/a><\/span>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Click here to ORDER an A++ paper from our Verified MASTERS and DOCTORATE WRITERS:NU 451 Women and Men\u2018s Health, Infectious Disease, and Hematologic Disorders<\/strong><\/a><\/span><\/p>\n The case is about a 46-year-old with hot flushes, night sweats, and genitourinary symptoms that began one month ago. She has a family history of breast cancer, history of HTN, and ASCUS. Her current BP is 150\/90, and her weight is 230 lbs. The patient\u2019s health needs include genitourinary and vasomotor, weight management, blood pressure management, and decreasing the risk of cervical and breast cancer. The vasomotor symptoms include night sweats and hot flushes, which can be linked to perimenopause (Pinkerton et al., 2019). The family history of breast cancer and history of ASCUS on Pap smear increases her risk of breast and cervical cancer. Besides, obesity and HTN increase her risk of heart disease, stroke, and obesity.<\/p>\n The recommended therapy is hormonal replacement therapy (HRT), with combined estrogen and progesterone. I would recommend a transdermal formulation like Estradiol 25 mcg patch for estrogen replacement. Estrogen is the primary active constituent of hormonal therapy and is considered the gold standard for managing perimenopausal vasomotor symptoms (Palacios et al., 2019). However, unopposed estrogen increases the risk of endometrial hyperplasia. Thus, I will recommend intravaginal progesterone 100 mg to restore progesterone.<\/p>\n The teach-back technique evaluates patients\u2019 understanding by asking them to explain in their words what they have understood on ways to improve their health. A nurse can use this approach to verify that they have explained things in a way that the patient understands. Therefore, I would recommend the teach-back strategy to educate this client on measures to reduce the severity of hot flushes, like wearing light clothing and using fans to control room temperature (Ward & Deneris, 2018). The strategy will also be applied to educate the patient on lifestyle modification interventions to promote weight loss and lower BP, like increasing physical exercises and reducing caloric dietary intake. Palacios, S., Stevenson, J. C., Schaudig, K., Lukasiewicz, M., & Graziottin, A. (2019). Hormone therapy for first-line management of menopausal symptoms: Practical recommendations.\u00a0Women’s Health (London, England)<\/em>,\u00a015<\/em>, 1745506519864009. https:\/\/doi.org\/10.1177\/1745506519864009<\/a><\/p>\n Pinkerton, J. V., Conner, E. A., & Kaunitz, A. M. (2019). Management of menopause and the role For hormone therapy.\u00a0Clinical Obstetrics and Gynecology<\/em>,\u00a062<\/em>(4), 677-686. https:\/\/doi.org\/10.1097\/GRF.0000000000000487<\/a><\/p>\nWomen and Men\u2018s Health, Infectious Disease, and Hematologic Disorders<\/span><\/b>\u00a0<\/span><\/h2>\n
Case Study 1<\/span><\/b>\u00a0<\/span><\/h3>\n
NU 451 Women and Men\u2018s Health, Infectious Disease, and Hematologic Disorders References<\/span><\/b>\u00a0<\/span><\/h3>\n
Case Study 2<\/span><\/b>\u00a0<\/span><\/h3>\n
![\"NU](\"https:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2023\/03\/NU-451-Women-and-Men\u2018s-Health-Infectious-Disease-and-Hematologic-Disorders-300x142.png\")
NU 451 Women and Men\u2018s Health, Infectious Disease, and Hematologic Disorders References<\/span><\/b>\u00a0<\/span><\/h3>\n
Women\u2019s and Men\u2019s Health, Infectious Disease, and Hematologic Disorders<\/strong><\/h3>\n
\n<\/strong><\/p>\nNU 451 Women and Men\u2018s Health, Infectious Disease, and Hematologic Disorders References<\/strong><\/h3>\n